DE602005027502D1 - Derivate des biologisch aktiven Peptids VAPEEHPTLLTEAPLNPK - Google Patents

Derivate des biologisch aktiven Peptids VAPEEHPTLLTEAPLNPK

Info

Publication number
DE602005027502D1
DE602005027502D1 DE602005027502T DE602005027502T DE602005027502D1 DE 602005027502 D1 DE602005027502 D1 DE 602005027502D1 DE 602005027502 T DE602005027502 T DE 602005027502T DE 602005027502 T DE602005027502 T DE 602005027502T DE 602005027502 D1 DE602005027502 D1 DE 602005027502D1
Authority
DE
Germany
Prior art keywords
peptide
vapeehptllteaplnpk
derivatives
biologically active
active peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005027502T
Other languages
English (en)
Inventor
Wai Ming Wong
Kong Lam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CMS Peptides Patent Holding Co Ltd
Original Assignee
CMS Peptides Patent Holding Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CMS Peptides Patent Holding Co Ltd filed Critical CMS Peptides Patent Holding Co Ltd
Publication of DE602005027502D1 publication Critical patent/DE602005027502D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE602005027502T 2004-04-28 2005-04-25 Derivate des biologisch aktiven Peptids VAPEEHPTLLTEAPLNPK Active DE602005027502D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56645504P 2004-04-28 2004-04-28

Publications (1)

Publication Number Publication Date
DE602005027502D1 true DE602005027502D1 (de) 2011-05-26

Family

ID=34967983

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005027502T Active DE602005027502D1 (de) 2004-04-28 2005-04-25 Derivate des biologisch aktiven Peptids VAPEEHPTLLTEAPLNPK

Country Status (18)

Country Link
US (1) US7718764B2 (de)
EP (2) EP1756152A2 (de)
JP (1) JP4689664B2 (de)
KR (1) KR101323771B1 (de)
CN (1) CN1976947B (de)
AT (1) ATE505483T1 (de)
AU (1) AU2005238173B2 (de)
CA (1) CA2564179C (de)
DE (1) DE602005027502D1 (de)
DK (1) DK2058328T3 (de)
ES (1) ES2365084T3 (de)
HK (1) HK1126790A1 (de)
NZ (1) NZ551595A (de)
PT (1) PT2058328E (de)
RU (1) RU2377249C2 (de)
TW (1) TWI353252B (de)
WO (1) WO2005105832A2 (de)
ZA (1) ZA200608865B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110234334B (zh) * 2016-12-05 2024-02-06 大塚制药株式会社 肌肉萎缩抑制组合物
CA3160917A1 (en) * 2019-12-06 2021-06-10 Cooke Aquaculture Inc. Peptides for regulating glucose
CN112812171B (zh) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
DE69433299T2 (de) 1993-06-15 2004-09-09 E.I. Du Pont De Nemours And Co., Wilmington Rekombinante spinnerseide analoge
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
JPH10503643A (ja) 1994-06-17 1998-04-07 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー 微生物中に遺伝物質を導入する方法およびその方法によってえられる形質転換体
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
ATE273322T1 (de) 1995-10-24 2004-08-15 Chemo Sero Therapeut Res Inst Tfpi-verwandte peptide die das wachstums von glatten muskelzellen inhibieren
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
JP3366339B2 (ja) 1997-05-27 2003-01-14 ハニル シンセティック ファイバー カンパニー リミテッド 高効率発現ベクターを用いてサッカロミセスセレビジエから再組合蛋白質を製造する方法
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
WO2002068601A2 (en) * 2001-02-28 2002-09-06 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
CN1210294C (zh) 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号21的生物活性肽
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
JP4213581B2 (ja) * 2001-07-13 2009-01-21 シーエムエス・ペプタイズ・パテント・ホールディング・カンパニー・リミテッド 生物学的に活性なペプチド
JPWO2004055045A1 (ja) * 2002-12-16 2006-04-20 株式会社シーエーエフラボラトリーズ サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン
WO2004055042A1 (en) * 2002-12-18 2004-07-01 Pepharm R & D Limited Biologically active peptide conjugates

Also Published As

Publication number Publication date
NZ551595A (en) 2010-04-30
JP4689664B2 (ja) 2011-05-25
CN1976947A (zh) 2007-06-06
EP2058328A1 (de) 2009-05-13
WO2005105832A2 (en) 2005-11-10
ES2365084T3 (es) 2011-09-21
ZA200608865B (en) 2009-06-24
RU2006137699A (ru) 2008-04-27
CN1976947B (zh) 2010-05-05
AU2005238173B2 (en) 2010-12-23
KR101323771B1 (ko) 2013-10-29
HK1126790A1 (en) 2009-09-11
AU2005238173A1 (en) 2005-11-10
KR20070004895A (ko) 2007-01-09
CA2564179C (en) 2013-08-06
US20080125372A1 (en) 2008-05-29
EP1756152A2 (de) 2007-02-28
TW200538151A (en) 2005-12-01
ATE505483T1 (de) 2011-04-15
EP2058328B1 (de) 2011-04-13
CA2564179A1 (en) 2005-11-10
US7718764B2 (en) 2010-05-18
JP2008501642A (ja) 2008-01-24
WO2005105832A3 (en) 2006-06-22
PT2058328E (pt) 2011-07-01
RU2377249C2 (ru) 2009-12-27
TWI353252B (en) 2011-12-01
DK2058328T3 (da) 2011-06-27

Similar Documents

Publication Publication Date Title
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
PE20110102A1 (es) Derivados de n-(2-oxo-2-pirrolidinil-1-il)etil-2-amino-acetamida como inhibidores de proteinas de apoptosis (iap)
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
BRPI0506864A (pt) método para conjugar peptìdeos, peptìdeo conjugado, composto e sais, pró-drogas e solvatos farmaceuticamente aceitáveis destes, composição farmacêutica, uso de um composto, e, método para tratamento de doença
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
CY1115629T1 (el) Χρηση ενωσεων πεπτιδιου τρο και φαρμακευτικων συνθεσεων στην θεραπεια της αναιμιας
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
EA200701852A1 (ru) Производные аминокислот
ATE505483T1 (de) Derivate des biologisch aktiven peptids vapeehptllteaplnpk
RU2009102195A (ru) Белок-связывающие производные метотрексата и содержащие их лекарства
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
PE20050285A1 (es) Composicion farmaceutica que comprende analogos ciclicos de somatostatina
ATE465172T1 (de) Peptidträger für die verabreichung von arzneimitteln
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
DE602004017062D1 (de) Zusammensetzungen aus deramciclan und opioiden zur verwendung als schmerzmittel
WO2005035500A3 (en) Therapeutic agents useful for treating pain
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico
EA200501765A3 (ru) Средство для лечения болезней суставов
DE10390702D2 (de) 2-Methylthiazolidin-2,4-Dicarbonsäure und deren Salze zur Behandlung von neurodegenerativen Erkrankungen
WO2007101252A3 (en) Targeted delivery of pharmaceutical compounds
RU2003125460A (ru) Биологически активный комплекс, содержащий фосфолипиды, для терапевтического использования